newsUS invests over $240 million into seven new COVID-19 diagnostic tests31 July 2020 | By Victoria Rees (European Pharmaceutical Review)The National Institutes of Health in the US has awarded contracts to seven biomedical companies to develop and manufacture COVID-19 diagnostics.